Effect of Subcutaneous Insulin Detemir on Glucose Flux, Lipolysis, and Electroencephalography during Euglycemia and Hyperglycemia in People with Type 1 Diabetes

被引：0
|
作者：
Herring, Roselle
Knight, Richard
Shojaee-Moradie, Fariba
Johnsen, Sigurd
Jackson, Nicola
Umpleby, Margot
Jones, Richard
Dijk, Derk-Jan
Russell-Jones, David
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2822-PO
引用
收藏
页码：A711 / A711
页数：1
相关论文
共 50 条
  • [1] Effect of subcutaneous insulin detemir on glucose flux, lipolysis and electroencephalography in type 1 diabetes
    Herring, R.
    Knight, R.
    Shojaee-Moradie, F.
    Johnsen, S.
    Umpleby, A. M.
    Jackson, N.
    Jones, R.
    Dijk, D. -J.
    Russell-Jones, D. L.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (11): : 1100 - 1103
  • [2] Effect of subcutaneous insulin detemir on glucose flux and lipolysis during hyperglycaemia in people with type 1 diabetes
    Herring, R. A.
    Shojaee-Moradie, F.
    Umpleby, A. M.
    Jones, R.
    Jackson, N.
    Russell-Jones, D. L.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (05): : 459 - 467
  • [3] The Effects of Subcutaneous Insulin NPH and Detemir on Glucose Flux and Lipolysis Following a Period of Insulin Withdrawal in Patients With Type 1 Diabetes
    Herring, Roselle
    Shojaee-Moradie, Fariba
    Jackson, Nicola
    Jones, Richard
    Umpleby, Margot
    Russell-Jones, David L.
    [J]. DIABETES, 2013, 62 : A492 - A492
  • [4] Glucose-lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes
    Derosa, G.
    Franzetti, I.
    Querci, F.
    Romano, D.
    D'Angelo, A.
    Maffioli, P.
    [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (06): : 554 - 559
  • [5] Effect of combined application insulin and insulin detemir on continous glucose monitor in children with type 1 diabetes mellitus
    Chen, Xiao-Yun
    Dong, Qing
    Li, Gui-Mei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 4287 - 4291
  • [6] Effect of Exercise Intensity on Glucose Requirements to Maintain Euglycemia During Exercise in Type 1 Diabetes
    Shetty, Vinutha B.
    Fournier, Paul A.
    Davey, Raymond J.
    Retterath, Adam J.
    Paramalingam, Nirubasini
    Roby, Heather C.
    Cooper, Matthew N.
    Davis, Elizabeth A.
    Jones, Timothy W.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (03): : 972 - 980
  • [7] Glucose-Dependent Insulinotropic Polypeptide (GIP) Induces Lipolysis during Stable Basal Insulin Substitution and Hyperglycemia in Men with Type 1 Diabetes
    Nielsen, Chris N.
    Heimburger, Sebastian M. Nguyen
    Calanna, Salvatore
    Holst, Jens J.
    Vilsboll, Tina
    Knop, Filip K.
    Christensen, Mikkel B.
    [J]. DIABETES, 2021, 70
  • [8] Subcutaneous insulin detemir compared with NPH insulin increases brain potential responses with similar systemic metabolic effects in people with Type 1 diabetes
    Herring, R.
    Shojaee-Moradie, F.
    Umpleby, M.
    Jackson, N.
    Jones, R.
    Derk-Jan, D.
    Knight, R.
    Russell-Jones, D.
    [J]. DIABETIC MEDICINE, 2014, 31 : 62 - 62
  • [9] Stable isotope studies show differences in effect of insulin detemir and NPH insulin on hepatic glucose output and peripheral glucose uptake after subcutaneous administration in subjects with type1 diabetes
    Hordern, VM
    Wright, JE
    Umpleby, M
    Jacobsen, L
    Draeger, E
    Russell-Jones, DL
    [J]. DIABETES, 2002, 51 : A292 - A292
  • [10] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with Type 1 diabetes
    Kolendorf, K
    Prasek, M
    Santeusanio, F
    Philotheou, A
    Gall, MA
    Heller, S
    [J]. DIABETOLOGIA, 2004, 47 : A329 - A329
12345